First evidence of ruxolitinib efficacy for subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis. Supporting rationale for ruxolitinib use, not more aggressive treatment, in this context, questioning this condition’s neoplastic nature.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160282 | PMC |
| http://dx.doi.org/10.1182/bloodadvances.2020001497 | DOI Listing |
Publication Analysis
Top Keywords
subcutaneous panniculitis-like
8
panniculitis-like t-cell
8
t-cell lymphoma
8
lymphoma hemophagocytic
8
hemophagocytic lymphohistiocytosis
8
efficacy ruxolitinib
4
ruxolitinib subcutaneous
4
lymphohistiocytosis evidence
4
evidence ruxolitinib
4
ruxolitinib efficacy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!